DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Innovision Limited — Action(s) taken or orders passed

NSE 1 hr ago·11 Sept 2026, 12:33 pm

Innovision

Innovision Limited has informed stock exchanges that regulatory authorities have taken action or passed orders against the company. This typically refers to enforcement actions by market regulators like SEBI or the Ministry of Corporate Affairs, which can range from inquiries to penalties.

For investors, this development is a key signal to exercise caution. It may indicate regulatory scrutiny over the company's financial reporting or compliance, potentially impacting its reputation and stock price volatility in the short term.

Investors should monitor the official regulatory filings for the specific nature of the order. Keeping an eye on the company's response and any further clarifications will be essential to understanding the long-term implications for its business operations.